Merus Labs

About:

The Merus corporate growth strategy is driven by a product acquisition plan which employs an opportunistic approach to source product

Website: http://www.meruslabs.com

Description:

The Merus corporate growth strategy is driven by a product acquisition plan which employs an opportunistic approach to source product acquisition candidates. This approach allows Merus to source pharmaceutical products across broad therapeutic classes which provides access to acquisition targets not available to other players and creates a diversified strategy. Although Merus has a broad therapeutic focus, opportunities will be pursued if the application of a dedicated small scale sales force can deliver incremental product sales growth. The geographic focus will be the United States and Canada

Total Funding Amount:

$74.3M

Headquarters Location:

Toronto, Ontario, Canada

Founded Date:

2012-01-01

Contact Email:

info(AT)meruslabs.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2015-04-30

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai